ProCE Banner Activity

Systemic Therapy Combinations for Early or Intermediate-Stage HCC: Current Evidence and Ongoing Trials

Slideset Download
Download this slideset for expert perspectives on emerging strategies in using immune checkpoint inhibitor combinations for patients with early- and intermediate-stage hepatocellular carcinoma.

Released: November 12, 2021

Expiration: November 11, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group

Faculty Disclosure

Primary Author

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas